CDE issues 3 guiding principles for clinical trial design of new drugs for advanced colorectal cancer
First-in-class Pharmaceutical Design Series: Prospects for the First Batch of Anti-COVID-19 Oral Drugs to Be Marketed in 2022
Qingdao Energy Institute designs anion-selective permeable polymer electrolyte to solve the bottleneck problem of dual-carbon batteries
Sibiman's dual-target CAR-T therapy received FDA regenerative medicine advanced therapy designation
JNNP: Model Design for Predicting Recovery Outcomes After Stroke
engineering to design a universal strategy for atomic-scale flexoelectricity
Design of synthetic route and judgment of reaction risk (1)
Design of synthetic route and judgment of reaction risk (2)
How to design targeted protein degradation agents more effectively?
Pfizer/BioNTech modified the trial design to evaluate the effect of enhanced needles for children 6 months to 5 years old
Researchers design a highly selective RIPK1 inhibitor with a dual mode of action of "alternative + competition"
Anti-aging new recruits scientists design "smart bombs" to remove old cells
Japan: All people from the United States will be quarantined in designated locations for 3 days
The investigative Alzheimer's disease treatment LECANEMAB was designated by the U.S. FDA for fast-track application
First-in-class drug design series: A review of the development of Pfizer’s oral anti-coronavirus drug Paxlovid
Express precise treatment of non-small cell lung cancer, FDA granted EGFR inhibitor breakthrough therapy designation
The Zhao Shizhen team of Shanghai Jiaotong University has made important progress in the design
The young guy suddenly "dementia", again this common medicine!
Novartis' next-generation IgE antibody application for clinical application has received FDA breakthrough therapy designation
From January to October, the assets of coal enterprises above designated size totaled 668.184 billion yuan